Clinical Trials Browser

Recruiting × BCG Vaccine × Clear all

NCT05037279 2025-02-20

EVER

Phase 3 Recruiting

Urinary Bladder Neoplasms, Recurrence

NCT06187506 2024-07-12

Disitamab Vedotin Combined With BCG Therapy in HER2-expressing High-risk Non-muscle Invasive Bladder Cancer

Phase 2 Recruiting

Non-Muscle Invasive Bladder Neoplasms